Zobrazeno 1 - 10
of 63
pro vyhledávání: '"G, Follerås"'
Autor:
Sverre Heim, Ludmila Gorunova, Bodil Bjerkehagen, Fredrik Mertens, G. Follerås, Clelia Tiziana Storlazzi, Fredrik Vult von Steyern, Nils Mandahl
Publikováno v:
Genes, Chromosomes and Cancer. 48:583-602
Giant cell tumor of bone (GCTB) is a benign but locally aggressive tumor with metastatic potential. We performed cytogenetic analysis on 10 1 GCTB from 92 patients. Karyotypes were obtained from 95 tumors, 47 of which had clonal aberrations. The majo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6aa7f1300569a7294447c7ee7cc64c17
https://doi.org/10.1002/gcc.20667
https://doi.org/10.1002/gcc.20667
Autor:
Clement S. Trovik, Peter Holmberg Jørgensen, Anders Walloe, Aarne Kivioja, Kalevi Hietaniemi, Carl Blomqvist, Henrik C. F. Bauer, G. Follerås, Peter Bergh
Publikováno v:
Acta Orthopaedica. 79:86-93
BACKGROUND: Giant cell tumors of bone rarely metastasize but often recur locally after surgery. There is limited knowledge about the risk of recurrence related to different types of treatment. PATIENTS AND METHODS: We analyzed factors affecting the l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::902cd0e2541bd7388ba4e0fc85824154
https://doi.org/10.1080/17453670710014815
https://doi.org/10.1080/17453670710014815
Autor:
Teddy Holmström, A. E. Stenwig, Thor Alvegård, Helena Willén, Gunnar Sæter, Christoph R. Müller, Sigbjørn Smeland, Aarne Kivioja, Tom Wiklund, Thomas Wiebe, Kjell Jonsson, Olle Björk, G. Follerås, Odd R. Monge, Otte Brosjö
Publikováno v:
European Journal of Cancer. 39:488-494
From 1990 to 1997, 113 eligible patients with classical osteosarcoma received neo-adjuvant chemotherapy consisting of high-dose methotrexate, cisplatin and doxorubicin. Good histological responders continued to receive the same therapy postoperativel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fffd9ceb80158f39e54470949e0cd0c8
https://doi.org/10.1016/s0959-8049(02)00747-5
https://doi.org/10.1016/s0959-8049(02)00747-5
Autor:
Henrik C. F. Bauer, Stephen R. Cannon, Robert J. Grimer, Reinhard Windhager, G. Follerås, I Meller, Gunnar Sæter, J. W. Van Der Eijken, Stefan S. Bielack, M Szendroi, Martin Dominkus, Beate Kempf-Bielack, Antoni H. M. Taminiau, Mikel San-Julian
Publikováno v:
European Journal of Cancer. 39:157-163
The European Musculo Skeletal Oncology Society (EMSOS) has carried out a retrospective review of patients over the age of 40 years with osteosarcoma. 481 patients from 12 centres or multicentric groups were included. 42 patients had osteosarcoma aris
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e17bed8ffb47583776e595dfac31db06
https://doi.org/10.1016/s0959-8049(02)00478-1
https://doi.org/10.1016/s0959-8049(02)00478-1
Autor:
Otte Brosjö, Katarina Engström, Erik Forestier, Gunnar Sæter, Odd R. Monge, Yngve Wahlqvist, Anna E. Stenwig, Thor Alvegård, Helena Willén, Hans Strander, G. Follerås, Teddy Holmström, Tom Wiklund, Thomas Wiebe
Publikováno v:
Europe PubMed Central
(1999). Chemotherapy in osteosarcoma. Acta Orthopaedica Scandinavica: Vol. 70, The Scandinavian Sarcoma Group: Twenty years' experience, pp. 74-82.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f19fe8471a12b5256686f1135ac2c10b
https://doi.org/10.1080/17453674.1999.11744828
https://doi.org/10.1080/17453674.1999.11744828
Autor:
L. H. Aksnes, Kirsten Sundby Hall, G. Follerås, N. L. Jebsen, Henrik C. F. Bauer, C. Allert, G. S. Haugen
Publikováno v:
The Journal of bone and joint surgery. British volume. 90(6)
We evaluated the long-term functional outcome in 118 patients treated for osteosarcoma or Ewing’s sarcoma in the extremities a minimum of five years after treatment. We also examined if impaired function influenced their quality of life and ability
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b1f0a212025d1c66348e4383ffe68da9
https://pubmed.ncbi.nlm.nih.gov/18539673
https://pubmed.ncbi.nlm.nih.gov/18539673
Autor:
Tom Böhling, Catarina Svarvar, Bodil Bjerkehagen, Kirsten Sundby Hall, Örjan Berlin, Pelle Gustafson, G. Follerås, Carl Blomqvist, Henryk A. Domanski, Erkki Tukiainen
Publikováno v:
Cancer. 109(2)
BACKGROUND. Leiomyosarcoma of nonvisceral soft tissues is an uncommon malignant tumor; thus, only small numbers of cases have been reported. This study was based on a large series of patients from the Scandinavian Sarcoma Group Register acquired duri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::463063893f8f7f2e3dd9ff9352eec89a
https://pubmed.ncbi.nlm.nih.gov/17154171
https://pubmed.ncbi.nlm.nih.gov/17154171
Autor:
Aarne Kivioja, P. Holmberg Jörgensen, Clement S. Trovik, G. Follerås, F Vult von Steyern, Henrik C. F. Bauer, Peter Bergh, Anders Rydholm
Publikováno v:
The Journal of bone and joint surgery. British volume. 88(4)
We retrospectively studied local recurrence of giant cell tumour in long bones following treatment with curettage and cementing in 137 patients. The median follow-up time was 60 months (3 to 166). A total of 19 patients (14%) had at least one local r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2d69493eb27fe7280a08d3e15b9a0455
https://pubmed.ncbi.nlm.nih.gov/16567792
https://pubmed.ncbi.nlm.nih.gov/16567792
Autor:
S, Smeland, C, Müller, T A, Alvegard, T, Wiklund, T, Wiebe, O, Björk, A E, Stenwig, H, Willén, T, Holmström, G, Follerås, O, Brosjö, A, Kivioja, K, Jonsson, O, Monge, G, Saeter
Publikováno v:
European journal of cancer (Oxford, England : 1990). 39(4)
From 1990 to 1997, 113 eligible patients with classical osteosarcoma received neo-adjuvant chemotherapy consisting of high-dose methotrexate, cisplatin and doxorubicin. Good histological responders continued to receive the same therapy postoperativel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::8956f7caa2e1080cd439a87adb36b72f
https://pubmed.ncbi.nlm.nih.gov/14602143
https://pubmed.ncbi.nlm.nih.gov/14602143
Autor:
Aarne Kivioja, Tom Wiklund, Teddy Holmström, Helena Willén, A. E. Stenwig, Thor Alvegård, Christoph R. Müller, Sigbjørn Smeland, Kjell Jonsson, Odd R. Monge, Otte Brosjö, G. Follerås, Gunnar Sæter, Olle Björk, Thomas Wiebe
From 1990 to 1997, 113 eligible patients with classical osteosarcoma received neo-adjuvant chemotherapy consisting of high-dose methotrexate, cisplatin and doxorubicin. Good histological responders continued to receive the same therapy postoperativel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::85c841b91275078ea1d7fa8be516bace
http://hdl.handle.net/11585/780713
http://hdl.handle.net/11585/780713
